Bayer plans to put $2.2 billion toward the construction of a new drug production site in Ohio, with a starting focus in oncology, cardiovascular and kidney therapies. Described as a modular campus that will span drug substance and product manufacturing, the site outside Columbus in New Albany is slated to create about 600 new jobs.…
GSK invests another $800M in Pennsylvania site expansions
GSK is expanding its footprint in Pennsylvania, with plans to invest $800 million in a biopharma research and manufacturing hub that’s expected to create more than 300 jobs in the next five years. New construction is slated to begin next year at facilities in Upper Merion Township outside Philadelphia, near the drugmaker’s U.S. headquarters —…